SHARON HUSUNG: Open Payments
NPI 1952959421 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 35 payments from 12 companies in 2025. Trend: 2023 $768 · 2024 $807 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $181 |
| Sumitomo Pharma America, Inc. | 9 | $147 |
| Astellas Pharma US Inc | 3 | $98 |
| MILLICENT US INC | 3 | $70 |
| Exact Sciences Corporation | 2 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Amgen Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| CooperSurgical, Inc. | 2 | $36 |
| Sage Therapeutics, LLC | 1 | $17 |
Products named: MYFEMBREE, Veozah, Cologuard Collection Kit, FEMRING, EVENITY, GARDASIL 9, Paragard T 380A, Mirena.
Industry payments across NY — which companies pay providers there.
